Risk management in gastrointestinal endoscopy for patients receiving antithrombotic therapy
スポンサーリンク
概要
- 論文の詳細を見る
Invasive procedures have been carried out inadvertently owing to the carelessness of the endoscopist. At the Health Management Center in Toranomon Hospital, a new safety measure was introduced in August 2009. In this measure, the endoscopist directly interviews the patient regarding the status of medication of antithrombotic therapy just before examination, and attaches forceps valves of one of two colors. A blue forceps valve is attached for patients undergoing antithrombotic therapy, and a black forceps valve is attached for patients not undergoing antithrombotic therapy. At the Endoscopic Room in Toranomon Hospital, no such safety measure was introduced. Two years after introduction, a questionnaire survey was conducted in 10 endoscopists who conducted GI endoscopy at both centers regarding experiences of careless mistakes in the 2 years. In the 2 years, 6 cases of careless mistakes were reported by 5 endoscopists in the Endoscopic Room in Toranomon Hospital. No careless mistake was reported in the Health Management Center. This safety measure is expected to facilitate safer GI endoscopy for patients receiving antithrombotic therapy.
- 一般社団法人 日本消化器がん検診学会の論文
一般社団法人 日本消化器がん検診学会 | 論文
- The role of ultrasonic mass survey in the diagnosis of hepatocellular carcinoma
- Follow-up schedule for the people who have a negative result from the serum pepsinogen measuring procedure
- The problems of accuracy for secondary examination in mass survey for colorectal cancer.
- Cost-effectiveness analysis of follow-up examination for patients with adenoma in mass survey for colorectal cancer
- Mass screening for colorectal cancer according to the Health and Medical Services Law for the Aged:With special reference to target age and screening intervals